ZENI Stock Overview
Zenicor Medical Systems AB (publ), a medical technology company, provides products and solutions for the diagnosis of arrhythmia and stroke prevention. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Zenicor Medical Systems AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 2.98 |
| 52 Week High | SEK 7.85 |
| 52 Week Low | SEK 2.80 |
| Beta | 1.12 |
| 1 Month Change | 0% |
| 3 Month Change | -1.32% |
| 1 Year Change | -59.73% |
| 3 Year Change | -83.54% |
| 5 Year Change | -82.47% |
| Change since IPO | -75.97% |
Recent News & Updates
Recent updates
Here's Why Zenicor Medical Systems (NGM:ZENI) Has A Meaningful Debt Burden
Oct 18
With EPS Growth And More, Zenicor Medical Systems (NGM:ZENI) Is Interesting
Jan 31Should You Investigate Zenicor Medical Systems AB (publ) (NGM:ZENI) At kr12.40?
Apr 13Are Zenicor Medical Systems AB (publ)'s (NGM:ZENI) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Feb 17
Shareholder Returns
| ZENI | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | 0% | 0.4% | -2.7% |
| 1Y | -59.7% | -8.1% | 4.6% |
Return vs Industry: ZENI underperformed the Swedish Medical Equipment industry which returned -8.9% over the past year.
Return vs Market: ZENI underperformed the Swedish Market which returned 8.6% over the past year.
Price Volatility
| ZENI volatility | |
|---|---|
| ZENI Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.0% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SE Market | 11.4% |
| 10% least volatile stocks in SE Market | 3.2% |
Stable Share Price: ZENI has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ZENI's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 23 | Mats Palerius | zenicor.se |
Zenicor Medical Systems AB (publ), a medical technology company, provides products and solutions for the diagnosis of arrhythmia and stroke prevention. The company offers Zenicor-ECG, a system to detect and diagnose atrial fibrillation and other arrhythmias, as well as allows the patient to register ECG data during extended periods and transfer the date to a central ECG database, where the data is presented to the care provider through the Internet. It serves cardiology, stroke, medical, pediatrics, clinical physiology, and private clinics in the Nordics, Germany, Switzerland, Austria, Cyprus, and the Great Britain.
Zenicor Medical Systems AB (publ) Fundamentals Summary
| ZENI fundamental statistics | |
|---|---|
| Market cap | SEK 26.89m |
| Earnings (TTM) | -SEK 6.70m |
| Revenue (TTM) | SEK 31.80m |
0.8x
P/S Ratio-4.0x
P/E RatioIs ZENI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ZENI income statement (TTM) | |
|---|---|
| Revenue | SEK 31.80m |
| Cost of Revenue | SEK 4.11m |
| Gross Profit | SEK 27.69m |
| Other Expenses | SEK 34.38m |
| Earnings | -SEK 6.70m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.74 |
| Gross Margin | 87.08% |
| Net Profit Margin | -21.06% |
| Debt/Equity Ratio | 61.9% |
How did ZENI perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/04/29 04:47 |
| End of Day Share Price | 2024/01/31 00:00 |
| Earnings | 2024/03/31 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Zenicor Medical Systems AB (publ) is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Oscar Stjerngren | Danske Bank |